Prognostic Role of MELD-Lactate in Cirrhotic Patients’ Short- and Long-Term Prognosis, Stratified by Causes of Cirrhosis

Figure 1

Receiver operating characteristic curves of the scoring systems for (a) 15-day and (b) 5-year mortality and (c) calibration curve of the MELD-LA score for 15-day mortality in the whole study population. SOFA, sequential organ failure assessment; CLIF-SOFA, chronic liver failure-sequential organ failure assessment; MELD, model for end-stage liver disease; MELD-LA, model for end-stage liver disease-lactate.

(a)

(b)

(c)